DaVita Inc
NYSE:DVA

Watchlist Manager
DaVita Inc Logo
DaVita Inc
NYSE:DVA
Watchlist
Price: 165.51 USD 0.83% Market Closed
Market Cap: 13.6B USD
Have any thoughts about
DaVita Inc?
Write Note

Gross Margin
DaVita Inc

32.8%
Current
31%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
32.8%
=
Gross Profit
4.2B
/
Revenue
12.7B

Gross Margin Across Competitors

Country US
Market Cap 13.7B USD
Gross Margin
33%
Country US
Market Cap 91.8B USD
Gross Margin
11%
Country US
Market Cap 87.7B EUR
Gross Margin
11%
Country US
Market Cap 73B USD
Gross Margin
14%
Country DE
Market Cap 24.9B EUR
Gross Margin
25%
Country US
Market Cap 20.1B USD
Gross Margin
28%
Country DE
Market Cap 18.8B EUR
Gross Margin
24%
Country US
Market Cap 18.3B USD
Gross Margin
33%
Country DE
Market Cap 12.4B EUR
Gross Margin
25%
Country AU
Market Cap 13.4B AUD
Gross Margin
84%
Country US
Market Cap 8.6B USD
Gross Margin
36%
No Stocks Found

DaVita Inc
Glance View

Market Cap
13.7B USD
Industry
Health Care

DaVita Inc. has emerged as a leading healthcare provider specializing in kidney care, operating over 2,800 outpatient dialysis centers across the United States and 10 additional countries. Founded in 1994, the company has made significant strides in enhancing the quality of life for individuals battling chronic kidney disease. With a mission deeply rooted in patient care, DaVita focuses on delivering comprehensive treatment and support, ensuring that patients receive not only dialysis services but also vital education and resources for managing their condition. This commitment to patient-centric care has positioned DaVita as a notable player in the burgeoning healthcare sector, making it an attractive investment opportunity for those interested in the resilience and growth potential within the industry. From an investor's perspective, DaVita represents a blend of stability and growth potential, driven by an aging population that increasingly requires kidney care services. The company benefits from a favorable reimbursement landscape and has implemented operational efficiencies that enhance profitability. In recent years, DaVita has also ventured into value-based care initiatives, which align incentives towards improved patient outcomes rather than volume. This strategic pivot not only secures a sustainable revenue model but also highlights the company’s adaptability in a rapidly changing healthcare environment. As such, DaVita stands out in the investment community, offering a chance to capitalize on a vital sector poised for expansion, all while contributing to the well-being of countless patients.

DVA Intrinsic Value
226.71 USD
Undervaluation 27%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
32.8%
=
Gross Profit
4.2B
/
Revenue
12.7B
What is the Gross Margin of DaVita Inc?

Based on DaVita Inc's most recent financial statements, the company has Gross Margin of 32.8%.